These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24614684)

  • 1. Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis.
    Chai D; Yue Y; Xu W; Dong C; Xiong S
    Hum Vaccin Immunother; 2014; 10(5):1284-94. PubMed ID: 24614684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis.
    Fan X; Yue Y; Xiong S
    Antiviral Res; 2017 Apr; 140():121-132. PubMed ID: 28137624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.
    Yin L; Chai D; Yue Y; Dong C; Xiong S
    Front Cell Infect Microbiol; 2017; 7():247. PubMed ID: 28642849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis.
    Wang M; Yue Y; Dong C; Li X; Xu W; Xiong S
    Clin Vaccine Immunol; 2013 Nov; 20(11):1743-51. PubMed ID: 24027262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine.
    Ye T; Yue Y; Fan X; Dong C; Xu W; Xiong S
    Vaccine; 2014 Jul; 32(35):4457-4465. PubMed ID: 24958702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIM2 co-immunization favors specific multifunctional CD8(+) T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis.
    Chai D; Yue Y; Xu W; Dong C; Xiong S
    Antiviral Res; 2015 Jul; 119():68-77. PubMed ID: 25956163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
    Yue Y; Xu W; Hu L; Jiang Z; Xiong S
    Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of immunogenicity and immunoprotection of mucosal vaccine against coxsackievirus B3 by optimizing the coadministration mode of lymphotactin adjuvant.
    Yue Y; Xu W; Xiong S
    DNA Cell Biol; 2012 Apr; 31(4):479-88. PubMed ID: 21988406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
    Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
    Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Albumin-Binding Domain Peptide Confers Enhanced Immunoprotection Against Viral Myocarditis by CVB3 VP1 Vaccine.
    Gao Y; Yue Y; Xiong S
    Front Immunol; 2021; 12():666594. PubMed ID: 34630378
    [No Abstract]   [Full Text] [Related]  

  • 11. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.
    Xu W; Shen Y; Jiang Z; Wang Y; Chu Y; Xiong S
    Vaccine; 2004 Sep; 22(27-28):3603-12. PubMed ID: 15315839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A novel DNA vaccine containing endosome-fusogenic peptide prevents CVB3-induced myocarditis in mice].
    Xu W; Shen Y; Chen RZ; Xiong SD
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):334-8. PubMed ID: 15059520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis.
    Wu F; Fan X; Yue Y; Xiong S; Dong C
    Vaccine; 2014 Jun; 32(31):3917-26. PubMed ID: 24874923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenteric CD103
    Zhao H; Yang J; Qian Q; Wu M; Li M; Xu W
    Front Immunol; 2018; 9():2986. PubMed ID: 30619341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An intranasal attenuated Coxsackievirus B3 vaccine induces strong systemic and mucosal immunity against CVB3 lethal challenge.
    Deng H; Li Y; He X; Wang H; Wang S; Zhang H; Zhu J; Gu L; Li R; Wang G
    J Med Virol; 2024 Aug; 96(8):e29831. PubMed ID: 39072815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-based delivery of VP1 protein conferred enhanced resistance of mice to CVB3-induced viral myocarditis.
    Zhang C; Zhang Y; Li Y; Lu J; Xiong S; Yue Y
    Virology; 2023 Feb; 579():46-53. PubMed ID: 36603532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
    Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H
    Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous C-cleavage of a truncated intein as fusion tag to produce tag-free VP1 inclusion body nanoparticle vaccine against CVB3-induced viral myocarditis by the oral route.
    Qi X; Lu Q; Hu J; Xiong S
    Microb Cell Fact; 2019 Apr; 18(1):66. PubMed ID: 30947747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.
    Zhang H; Morgan-Capner P; Latif N; Pandolfino YA; Fan W; Dunn MJ; Archard LC
    Am J Pathol; 1997 Jun; 150(6):2197-207. PubMed ID: 9176409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
    Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.